These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 1531757)

  • 1. Motor responses to dopamine D1 and D2 agonists in the reserpine-treated mouse are affected differentially by the NMDA receptor antagonist MK 801.
    Goodwin P; Starr BS; Starr MS
    J Neural Transm Park Dis Dement Sect; 1992; 4(1):15-26. PubMed ID: 1531757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the effects of NMDA and AMPA antagonists on the locomotor activity induced by selective D1 and D2 dopamine agonists in reserpine-treated mice.
    Starr MS; Starr BS
    Psychopharmacology (Berl); 1994 Apr; 114(3):469-76. PubMed ID: 7855205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Motor activation in short- and long-term reserpinized mice: role of N-methyl-D-aspartate, dopamine D1 and dopamine D2 receptors.
    Ferré S; Giménez-Llort L; Artigas F; Martínez E
    Eur J Pharmacol; 1994 Apr; 255(1-3):203-13. PubMed ID: 7913043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glutamate antagonists modify the motor stimulant actions of D1 and D2 agonists in reserpine-treated mice in complex ways that are not predictive of their interactions with the mixed D1/D2 agonist apomorphine.
    Starr MS; Starr BS
    J Neural Transm Park Dis Dement Sect; 1993; 6(3):215-26. PubMed ID: 7907216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Behavioural role of dopamine D1 receptors in the reserpine-treated mouse.
    Starr BS; Starr MS; Kilpatrick IC
    Neuroscience; 1987 Jul; 22(1):179-88. PubMed ID: 2957609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Facilitation of dopamine D1 receptor- but not dopamine D1/D2 receptor-dependent locomotion by glutamate antagonists in the reserpine-treated mouse.
    Starr MS; Starr BS
    Eur J Pharmacol; 1993 Dec; 250(2):239-46. PubMed ID: 7906652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of D1 receptor mechanisms in the potentiation of motor responses to L-dopa and apomorphine by MK 801 in the reserpine-treated mouse.
    Kaur S; Starr MS; Starr BS
    J Neural Transm Park Dis Dement Sect; 1994; 8(1-2):107-16. PubMed ID: 7893372
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-methyl-D-aspartate receptor antagonist and dopamine D1 and D2 agonist interactions in 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine-induced hemiparkinsonian monkeys.
    Domino EF; Sheng J
    J Pharmacol Exp Ther; 1993 Jan; 264(1):221-5. PubMed ID: 8093726
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential locomotor interactions between dopamine D1/D2 receptor agonists and the NMDA antagonist dizocilpine in monoamine-depleted mice.
    Svensson A; Carlsson A; Carlsson ML
    J Neural Transm Gen Sect; 1992; 90(3):199-217. PubMed ID: 1363051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of chronic treatment with dizocilpine (MK-801) on the behavioral response to dopamine receptor agonists in the rat.
    Dall'Olio R; Gandolfi O; Montanaro N
    Psychopharmacology (Berl); 1992; 107(4):591-4. PubMed ID: 1534911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
    Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN
    Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CY 208-243 behaves as a typical D-1 agonist in the reserpine-treated mouse.
    Abbott B; Starr BS; Starr MS
    Pharmacol Biochem Behav; 1991 Feb; 38(2):259-63. PubMed ID: 1676166
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of N-methyl-D-aspartate receptors in dopamine D1-, but not D2-, mediated changes in striatal and accumbens neurotensin systems.
    Singh NA; Bush LG; Gibb JW; Hanson GR
    Brain Res; 1992 Feb; 571(2):260-4. PubMed ID: 1351780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. N-methyl-D-aspartate receptor blockade attenuates D1 dopamine receptor modulation of neuronal activity in rat substantia nigra.
    Huang KX; Bergstrom DA; Ruskin DN; Walters JR
    Synapse; 1998 Sep; 30(1):18-29. PubMed ID: 9704877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of NMDA and MK-801 injected into the substantia nigra pars reticulata on jaw movements evoked by dopamine D1-/D2 receptor stimulation in the ventrolateral striatum: studies in freely moving rats.
    Uchida T; Lee J; Fujita S; Kiguchi M; Matsumoto M; Oi Y; Gionhaku N; Koshikawa N
    Methods Find Exp Clin Pharmacol; 2005; 27(1):31-7. PubMed ID: 15834457
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine-N-methyl-D-aspartate interactions in the modulation of locomotor activity and memory consolidation in mice.
    Mele A; Castellano C; Felici A; Cabib S; Caccia S; Oliverio A
    Eur J Pharmacol; 1996 Jul; 308(1):1-12. PubMed ID: 8836626
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opposite effects of NMDA receptor blockade on dopaminergic D1- and D2-mediated behavior in the 6-hydroxydopamine model of turning: relationship with c-fos expression.
    Morelli M; Fenu S; Pinna A; Di Chiara G
    J Pharmacol Exp Ther; 1992 Jan; 260(1):402-8. PubMed ID: 1346165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Locomotor effects of amantadine in the mouse are not those of a typical glutamate antagonist.
    Starr MS; Starr BS
    J Neural Transm Park Dis Dement Sect; 1995; 9(1):31-43. PubMed ID: 7605588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of dopamine-mediated behaviour by the NMDA antagonists MK-801 and CPP: similarities with repeated electroconvulsive shock.
    Smith SE; Acton L; Sharp T
    Psychopharmacology (Berl); 1997 Sep; 133(1):85-94. PubMed ID: 9335085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of NMDA receptor antagonists on D1, D2 and D1/D2 mediated behaviors in intact rats.
    Dall'Olio R; Rimondini R; Gandolfi O
    Psychopharmacology (Berl); 1996 Jan; 123(2):187-90. PubMed ID: 8741942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.